Skip to main content
Maria Rodriguez, MD, Oncology, San Antonio, TX, University of Texas M.D. Anderson Cancer Center

MariaA.RodriguezMD

Oncology San Antonio, TX

Physician

Dr. Rodriguez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rodriguez's full profile

Already have an account?

Summary

  • Dr. Maria Rodriguez is a pediatrician in San Antonio, TX.

Education & Training

  • University of Arizona College of Medicine-Tucson
    University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1983 - 1986
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1979 - 1982
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 1979

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2026
  • TN State Medical License
    TN State Medical License 2023 - 2025
  • WA State Medical License
    WA State Medical License 2023 - 2025
  • OK State Medical License
    OK State Medical License 2020 - 2025
  • AL State Medical License
    AL State Medical License 2023 - 2024
  • TX State Medical License
    TX State Medical License 2013 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • Fellow (FACP) American College of Physicians, 2001

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Phase II Trial of Nivolumab and Ibrutinib for Patients with Relapsed or Refractory Central Nervous System Lymphoma
    Maria Alma Rodriguez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Smart Start: Rituximab, Lenalidomide, and Ibrutinib Alone and in Combination with Standard Chemotherapy for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma...
    Maria Alma Rodriguez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell LymphomaRadiation Therapy Can be ...
    Maria Alma Rodriguez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Analysis of financial sustainability of survivorship clinics led by advanced practice providers. 
    2019 ASCO Annual Meeting - 6/1/2019

Professional Memberships

Hospital Affiliations